| My Account | Subscribe | Contact Us | Donate |
Home
-
Diabetes and Adoption
Rachel and her husband chose to adopt a baby instead of meeting the challenges of handling a high risk pregnancy and Rachel’s type 1 diabetes at the same time. She shares their thought process and ultimate happy ending about the decision to bring a child into their lives.
-
Chris Matthews Makes Time for Diabetes
Hosting Hardball on MSNBC and The Chris Matthews Show keep Chris Matthews working long hours. But Matthews got a lesson in priorities and made some life changes when he was diagnosed with type 2.
-
A Chihuahua with Diabetes
Olivia and her dog both have diabetes and today they comfort and encourage each other through the rigors of dealing with the disease. Plus, find out what it means when your domestic pet is diagnosed with diabetes.
-
Smoking and Diabetes
Smoking has severe effects on your diabetes and your health. Learn why diabetes and smoking are an especially bad combination and get some tips from the experts on how to quit.
-
Continuous Glucose Monitors
CGM is a relatively new technology, but the information it provides is invaluable. Find out what CGM offers and whether it could help you.
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
Latest The Cure Articles
This Week's Diabetes Research Highlights
Tekturna Reduces Kidney Disease Indicator
The blood pressure medicine Tekturna (aliskiren) may have a beneficial side effect for people with type 2 diabetes and high blood pressure who are at risk of kidney disease. According to a recent article in The New England Journal of Medicine, the drug reduces proteinuria, a key indicator of kidney disease, by 20 percent in patients with type 2 diabetes.
The reduction depends, however, on administering Tekturna along with a maximum dose of the kidney disease treatment drug losartan. (Read the NEJM abstract.)
Metabolic Syndrome Has Genetic Markers
Researchers say that people who have five common gene variations run a greater risk of developing metabolic syndrome, the cluster of symptoms whose sufferers are far more likely to develop heart disease and diabetes than people without it.
Researchers at Washington University School of Medicine in St. Louis found the variations on the CD36 gene, located in a part of chromosome 7 that has previously been associated with metabolic syndrome in other studies.
The DNA they studied came from more than 2,000 African-Americans, a group in which those genetic variations are more common. Researchers expect that their findings will apply to other populations. This press release has more information.
Insulin Delivery Company Says Analogs Are Over-Rated
Keep an eye out for a resurgence in the debate over the efficacy of insulin analogs, thanks to research presented at the Endocrine Society’s recent annual meeting in San Francisco.
Researchers from the Institute for Endocrinology IEMYR in Quito, Ecuador, and the University of Florida at Gainesville studied 26 type 1 patients over a one-year period to compare the performance of analog and non-analog insulins.
They found that the combination of a long-acting, non-analog basal insulin taken twice daily and “Oral-lyn,” a liquid formulation of human insulin, works better at lowering A1c’s, fructosamine levels and pre-meal blood glucose levels than a once-a-day basal dose of the insulin analog glargine and a faster-acting analog before meals.
The study was sponsored by Generex Biotechnology, an insulin delivery manufacturer and the maker of Oral-lyn. Oral-lyn is currently undergoing testing in the United States for FDA approval. This press release has more details.
Categories: New Cure Research, The Cure
Facebook
MySpace 
Digg
Email to a Friend
Send a link to this page to your friends and colleagues.